GB1469472A - Non-immunogenic polypeptides and processes for preparing same - Google Patents
Non-immunogenic polypeptides and processes for preparing sameInfo
- Publication number
- GB1469472A GB1469472A GB3186174A GB3186174A GB1469472A GB 1469472 A GB1469472 A GB 1469472A GB 3186174 A GB3186174 A GB 3186174A GB 3186174 A GB3186174 A GB 3186174A GB 1469472 A GB1469472 A GB 1469472A
- Authority
- GB
- United Kingdom
- Prior art keywords
- biocatalyst
- processes
- preparing same
- immunogenic polypeptides
- polyalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
- C12N11/089—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Toxicology (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Peptides Or Proteins (AREA)
Abstract
A method for suppressing the immunogenic action of a biocatalyst which has a large number of peptide linkages, with at least partial retention of its physiological activity, entails attaching polymers to the biocatalyst; the biocatalyst is attached to a virtually linear polyalkyl or polyalkoxy polymer via at least one terminal carbon atom thereof; the polyalkyl or polyalkoxy polymer is unsubstituted or substituted by an alkoxy or alkyl group containing fewer than 5 C atoms.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38119173A | 1973-07-20 | 1973-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1469472A true GB1469472A (en) | 1977-04-06 |
Family
ID=23504063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3186174A Expired GB1469472A (en) | 1973-07-20 | 1974-07-18 | Non-immunogenic polypeptides and processes for preparing same |
Country Status (9)
Country | Link |
---|---|
JP (1) | JPS5623587B2 (en) |
CA (1) | CA1033673A (en) |
CH (1) | CH616942A5 (en) |
DE (1) | DE2433883C2 (en) |
FR (1) | FR2313939A1 (en) |
GB (1) | GB1469472A (en) |
IL (1) | IL45291A0 (en) |
NL (1) | NL7409770A (en) |
SE (1) | SE441753B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5037969A (en) * | 1986-07-03 | 1991-08-06 | Takeda Chemical Industries, Ltd. | Glycosyl derivatives and use thereof |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US5578496A (en) * | 1991-12-19 | 1996-11-26 | Board Of Regents, Baylor College Of Medicine | Detection of autoantibodies associated with the disease myasthenia gravis |
US5618528A (en) * | 1994-02-28 | 1997-04-08 | Sterling Winthrop Inc. | Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
US6048529A (en) * | 1991-12-19 | 2000-04-11 | Atassi; M. Zouhair | PVA or PEG conjugates of peptides for epitope-specific immunosuppression |
WO2006135930A2 (en) * | 2005-06-13 | 2006-12-21 | Nastech Pharmaceutical Company Inc. | Transmucosal delivery of peptide derivatives |
US7790835B2 (en) | 2003-12-03 | 2010-09-07 | Nektar Therapeutics | Method of preparing maleimide functionalized polymers |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2930542A1 (en) * | 1979-07-27 | 1981-02-12 | Hoechst Ag | NEW INSULINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
JPS58145691U (en) * | 1982-03-29 | 1983-09-30 | 株式会社タイト− | table type video game machine |
JPS5976288U (en) * | 1982-11-15 | 1984-05-23 | 大平技研工業株式会社 | table type video game machine |
WO1985003934A1 (en) * | 1984-03-06 | 1985-09-12 | Takeda Chemical Industries, Ltd. | Chemically modified protein and process for its preparation |
JPS59204130A (en) * | 1983-04-30 | 1984-11-19 | Nippon Chemiphar Co Ltd | Oral administration drug containing novel plasminogen activator derivative |
DE3334407A1 (en) * | 1983-09-23 | 1985-04-04 | Hoechst Ag, 6230 Frankfurt | INSULINE DERIVATIVES MODIFIED IN POSITION B 30, METHOD FOR THE PRODUCTION AND USE THEREOF AND PHARMACEUTICAL AGENTS FOR THE TREATMENT OF THE DIABETES MELLITUS |
JPH0327674Y2 (en) * | 1984-10-02 | 1991-06-14 | ||
JPS61163687U (en) * | 1985-03-28 | 1986-10-09 | ||
JPS62207485A (en) * | 1986-03-07 | 1987-09-11 | 大平技研工業株式会社 | Television game machine |
WO2001017564A2 (en) * | 1999-09-10 | 2001-03-15 | The Procter & Gamble Company | Enzyme inhibitors |
US6323311B1 (en) | 1999-09-22 | 2001-11-27 | University Of Utah Research Foundation | Synthesis of insulin derivatives |
IL161251A0 (en) * | 2001-10-10 | 2004-09-27 | Neose Technologies Inc | Remodeling and glycoconjugation of peptides |
MXPA04003597A (en) | 2001-10-18 | 2004-07-30 | Nektar Therapeutics Al Corp | Polymer conjugates of opioid antagonists. |
JP2005528372A (en) * | 2002-03-26 | 2005-09-22 | バイオシネクサス インコーポレイテッド | Antibacterial polymer composite |
US20040062748A1 (en) * | 2002-09-30 | 2004-04-01 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
JP5030383B2 (en) * | 2002-10-21 | 2012-09-19 | アルヴィヴォ インコーポレイテッド | Surface coating containing bioactive compounds |
ATE492562T1 (en) | 2003-09-24 | 2011-01-15 | Kyowa Hakko Kirin Co Ltd | RECOMBINANT ANTIBODY AGAINST HUMAN INSULIN-LIKE GROWTH FACTOR |
US7301003B2 (en) * | 2005-08-26 | 2007-11-27 | Enzon Pharmaceuticals, Inc. | Method of preparing polymers having terminal amine groups |
US10046058B2 (en) * | 2014-12-02 | 2018-08-14 | Rezolute, Inc. | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates |
US20170342211A1 (en) * | 2016-05-31 | 2017-11-30 | Robert Bosch Gmbh | Azlactone functionalized substrates for conjugation of biomolecules |
EP4019007A1 (en) * | 2016-06-01 | 2022-06-29 | Servier IP UK Limited | Formulations of polyalkylene oxide-asparaginase and methods of making and using the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE337223B (en) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
US3619371A (en) * | 1967-07-03 | 1971-11-09 | Nat Res Dev | Production of a polymeric matrix having a biologically active substance bound thereto |
US3674767A (en) * | 1967-07-14 | 1972-07-04 | Nat Res Dev | Novel polymeric materials containing triazinyl groups |
-
1974
- 1974-07-15 DE DE2433883A patent/DE2433883C2/en not_active Expired
- 1974-07-17 IL IL45291A patent/IL45291A0/en unknown
- 1974-07-18 GB GB3186174A patent/GB1469472A/en not_active Expired
- 1974-07-18 SE SE7409366A patent/SE441753B/en not_active IP Right Cessation
- 1974-07-19 CH CH997274A patent/CH616942A5/en not_active IP Right Cessation
- 1974-07-19 NL NL7409770A patent/NL7409770A/en unknown
- 1974-07-19 FR FR7425288A patent/FR2313939A1/en active Granted
- 1974-07-19 CA CA205,144A patent/CA1033673A/en not_active Expired
- 1974-07-20 JP JP8373374A patent/JPS5623587B2/ja not_active Expired
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5037969A (en) * | 1986-07-03 | 1991-08-06 | Takeda Chemical Industries, Ltd. | Glycosyl derivatives and use thereof |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
US5578496A (en) * | 1991-12-19 | 1996-11-26 | Board Of Regents, Baylor College Of Medicine | Detection of autoantibodies associated with the disease myasthenia gravis |
US6048529A (en) * | 1991-12-19 | 2000-04-11 | Atassi; M. Zouhair | PVA or PEG conjugates of peptides for epitope-specific immunosuppression |
US5618528A (en) * | 1994-02-28 | 1997-04-08 | Sterling Winthrop Inc. | Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
US5853713A (en) * | 1994-02-28 | 1998-12-29 | Sterling Winthrop Inc. | Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
US8039579B2 (en) | 2003-12-03 | 2011-10-18 | Nektar Therapeutics | Intermediates useful in the preparation of maleimide functionalized polymers |
US7790835B2 (en) | 2003-12-03 | 2010-09-07 | Nektar Therapeutics | Method of preparing maleimide functionalized polymers |
US8258324B2 (en) | 2003-12-03 | 2012-09-04 | Nektar Therapeutics | Intermediates useful in the preparation of maleimide functionalized polymers |
US8653286B2 (en) | 2003-12-03 | 2014-02-18 | Nektar Therapeutics | Intermediates useful in the preparation of maleimide functionalized polymers |
US8895759B2 (en) | 2003-12-03 | 2014-11-25 | Nektar Therapeutics | Intermediates useful in the preparation of maleimide functionalized polymers |
WO2006135930A3 (en) * | 2005-06-13 | 2007-05-31 | Nastech Pharm Co | Transmucosal delivery of peptide derivatives |
WO2006135930A2 (en) * | 2005-06-13 | 2006-12-21 | Nastech Pharmaceutical Company Inc. | Transmucosal delivery of peptide derivatives |
Also Published As
Publication number | Publication date |
---|---|
CA1033673A (en) | 1978-06-27 |
DE2433883A1 (en) | 1976-02-05 |
DE2433883C2 (en) | 1986-03-27 |
JPS5042087A (en) | 1975-04-16 |
FR2313939B1 (en) | 1979-05-18 |
SE7409366L (en) | 1975-01-21 |
SE441753B (en) | 1985-11-04 |
IL45291A0 (en) | 1974-10-22 |
CH616942A5 (en) | 1980-04-30 |
JPS5623587B2 (en) | 1981-06-01 |
NL7409770A (en) | 1975-01-22 |
FR2313939A1 (en) | 1977-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1469472A (en) | Non-immunogenic polypeptides and processes for preparing same | |
ZM2074A1 (en) | Water-dispersible high molecular weight polymer compositions | |
ES462425A1 (en) | Method of preparing novel bitumen compositions | |
CA1021899A (en) | Self-extinguishing polymer compositions containing hexabromo-2-butene | |
ES447679A1 (en) | Particulate expandable styrene polymers having good processability | |
NO166451C (en) | PROCEDURE FOR PREPARING A SOLUTION OF A SOLUBLE POLYMER. | |
JPS526796A (en) | Process for preparing polyester elastomers | |
ES451701A1 (en) | 6{62 ,17-Dihydroxy-7{60 -(lower alkoxy)carbonyl-3-oxo-17{60 -pregn-4-ene-21-carboxylic acid {65 -lactones and congeners | |
ES440055A1 (en) | 19,20-Bis-nor-prostenoic acids as hypolipemic compounds | |
BE832247A (en) | O-CHLORANILE AND 5,6,11,12-TETRASELENOTETRACENE COMPLEXES, USED AS ORGANIC CONDUCTIVE ELEMENTS | |
AU6873174A (en) | Phenyl-and %substituted<-phenyl-1,2,3-triazole-alkonoic and- alkenoic acids | |
SU651409A1 (en) | Magnetic record carrier working layer binder | |
ES427869A1 (en) | 5-phenyl-sulphinyl-2-benzimidazolyl-carbamic acid esters and process for their manufacture | |
ES429691A1 (en) | Preparation of p-isobutyl hydratropic acid and intermediates therefor | |
ES394637A1 (en) | Vinyl esters polymers containing hindered phenolic groups | |
ZM9378A1 (en) | Use of cyclic esters to prepare 2,3-dichloro-4-(2-thenoyl) phenoxyacetic acid | |
JPS51136784A (en) | Method f or preparing a polymer containing a a skelton of stabilizer in the molecule | |
JPS5240600A (en) | Improved process for preparing ring-opening polymer | |
JPS5247899A (en) | Process for preparing polymers of norbornene derivatives | |
ES403361A1 (en) | Controlled polymerization of hexachlorophosphazene | |
IE41250L (en) | 2,2-bis-hydroxymethylalkanesulphonate polymer modifiers | |
JPS5263298A (en) | Improved process for preparing ring opening polymer | |
GB1352024A (en) | Process of producing substituted benzotriazole isothiocyanates of a high antimicrobial activity | |
ES436615A1 (en) | Antibiotics | |
ES417166A1 (en) | Procedure for the preparation of stainless insoluble and infusible synthetic products in storage and thermo-dependable. (Machine-translation by Google Translate, not legally binding) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19940717 |